Yubo International Biotech Limited (MAGAA) Annual Balance Sheets

Annual · GAAP · USD millions
Access MAGAA quarterly Balance Sheets →
From Yubo International Biotech Limited through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.00
Security Deposit0.02
Cash & Short-term Investments0.00
Accounts receivable0.14
Due from Related Parties AS0.00
Inventories0.02
Other Current Assets0.28
Prepaid Expense, Current AS0.21
Total Current Assets0.67
Equipment/Property/Plant Net0.04
Intangible Assets0.04
Other Assets, Noncurrent0.09
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.01
Outstanding Balances With Affiliated Parties-
Operating Lease Right Of Use Asset-
Total Assets0.85
Liabilities
Accounts Payable1.06
Accounts Payable and Other Accrued Liabilities0.00
Other Liabilities, Current1.73
Customer Deposits, Current0.00
Total Current Liabilities2.79
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.08
Total Liabilities2.79
Stockholders' Equity
Common Stock Value0.17
Additional Paid In Capital Common Stock5.47
Retained Earnings / Accumulated Deficit-7.74
Other Equity0.15
Common Stockholder's Equity-1.95
Non-controlling interests & other0.01
Total Stockholder's Equity-1.94
Liabilities & Stockholder's Equity0.85
4 historic quarters locked

Sign in to unlock the full Yubo International Biotech Limited balance sheet history.

About Yubo International Biotech Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: yubo_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-26-000598

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License